Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

This study has been terminated.
(PI left VICC)
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Ingrid Mayer, MD, Vanderbilt-Ingram Cancer Center
ClinicalTrials.gov Identifier:
NCT00082667
First received: May 14, 2004
Last updated: February 22, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2005
  Primary Completion Date: July 2004 (Final data collection date for primary outcome measure)